Nelson Advisors invited to Judge the MedTech Startup Pitch Awards at MedTech Europe 2025. The MedTech Malta Startup Pitch is a platform for medical technology startups to showcase their innovative products, services, and solutions to a panel of judges and potential investors. This shall provide a unique opportunity for entrepreneurs to gain exposure, receive feedback, and secure funding for their ventures.

This report provides a definitive analysis for venture capital (VC) investment in the value-based care (VBC) healthtech sector. While VBC represents a profound and necessary paradigm shift with a multi-trillion-dollar market opportunity, it is not an environment for unsophisticated capital. The core finding is a qualified "yes": venture capital should strategically back VBC healthtech, but only by targeting specific business models and deploying patient capital with a deep

Subconscious vibro-tactile stimulation (VTS) represents a powerful, emerging modality within the HealthTech sector, positioned to transition from a specialised clinical tool to a ubiquitous component of personalised healthcare. Defined as the application of non-invasive mechanical vibration to the skin to modulate neural activity, VTS operates on an implicit level, leveraging the body's natural sensory and proprioceptive systems to effect therapeutic changes in the brain and

For High-Growth HealthTech Startups: When planning a fundraising or exit event, it is recommended to engage with a specialised boutique advisor like Nelson Advisors, with their "founders for founders" approach, they can offer a more tailored and empathetic perspective. Their deep understanding of the market niche and hands-on guidance can be more valuable for maximising shareholder value than the broad, standardised services of a larger generalist firm.

TIME has released its inaugural "World's Top HealthTech Companies 2025" list, in partnership with Statista. The ranking highlights 400 companies from over 25 countries across six market segments. The companies were evaluated based on a combination of financial performance, reputation analysis, and online engagement.

The current healthcare innovation economy presents a compelling and complex paradox for investors. The broader US healthcare venture capital fundraising landscape has experienced a significant decline, with the total for the first half of 2025 at just $3 Billion, a steep drop from the previous year. This puts the sector on track for its worst fundraising year in over a decade. This market contraction is largely attributed to economic and political uncertainty, coupled with a

Nelson Advisors Partner Lloyd Price will Chair the panel discussing the European HealthTech Investment Landscape, covering key questions such as: Which countries or regions in Europe are emerging as HealthTech hubs? Beyond the traditional powerhouses like the UK, Germany, and France, are there new centers of innovation, particularly in Central and Eastern Europe (CEE)? How are macroeconomic factors impacting the market? How are rising interest rates and inflation affecting d

European HealthTech Market Analysis - September 2025: Transition from Fragmented Point Solutions into Critical Healthcare Infrastructure....

The field of vagus nerve neuromodulation (VNN) is undergoing a profound transformation, moving beyond its established applications to emerge as a cornerstone of bioelectronic medicine. While vagus nerve stimulation (VNS) has long been a recognised treatment for refractory epilepsy and treatment-resistant depression, recent technological breakthroughs and landmark clinical trial results are expanding its therapeutic reach into a wide array of chronic inflammatory, neurological

Nelson Advisors LLP, a UK-based firm, is explicitly and exclusively focused on providing mergers and acquisitions (M&A) advisory services within the healthcare technology sector across the United Kingdom, Europe, and North America. The firm’s core value proposition is rooted in a distinctive "practitioner-led" approach. This model is a direct function of the synergistic partnership between its two co-founders, whose professional backgrounds combine extensive corporate finance

The European HealthTech and MedTech sectors are undergoing a profound transformation, moving from a fragmented, early-stage ecosystem to a mature, consolidating landscape ripe for sophisticated private equity (PE) strategies. This report serves as a strategic blueprint for PE firms aiming to capitalise on this evolution. The analysis reveals that the European digital health market has emerged as a global leader in funding growth, propelled by a strategic pivot towards fewer,

The European digital health market is at a pivotal inflection point, with the musculoskeletal (MSK) sector emerging as a primary frontier for innovation and investment. This market is not merely growing; it is undergoing a fundamental transformation, driven by an aging demographic, the increasing prevalence of chronic conditions, and a critical shift towards data-enabled, value-based care. The European Digital MSK market is projected to reach a revenue of US$3.28 Billion by 2

Ambient Voice Technology in the UK: Research Series by Nelson Advisors. The Accelerating UK NHS Ambient Voice Technology Market: Dynamics, Key Players, and Strategic Imperatives report. Ambient Voice Technology and the NHS 10 Year Plan: Strategy, Future Applications, Key Suppliers, Funding and Regulatory Landscape. NHS Ambient Voice Technology Market Heats Up in the UK - key players include TORTUS AI, Heidi Health, ClinicLetter.ai, Scribetech, Suki, Nuance, Tandem.

Lloyd Price, partner at HealthTech M&A firm Nelson Advisors, said the London results were encouraging on that front also. He said: “One of the biggest takeaways from the GOSH trial is the high level of public comfort and consent rate to using ambient voice technologies. To generate all of the productivity and efficiency gains, patients/carers/parents need to agree to being recorded and transcribed. Without high levels of public trust, technology solutions will struggle to be

The relationship between medical technology (MedTech) and defence technology has historically been characterised by an ad hoc, one-directional flow of innovation, often described as a "spin-out" effect where military research unexpectedly finds civilian applications. However, a contemporary analysis reveals a more complex, mutually beneficial, and increasingly institutionalized symbiosis. This interdependence is no longer a matter of serendipitous discovery but a deliberate,